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Abstract
Bioactive glasses have been developed for medical applications in the body for bone
and tissue repair and regeneration. We have developed a borate-containing bioactive
glass (13-93B3, referred to as B3), which is undergoing clinical trials to assess its
wound-healing properties. To complement the healing properties of B3, metal ion
dopants have been added to enhance its antimicrobial properties. Bioactive glasses
doped with silver, gallium or iodine ions were found to have broad spectrum antimicrobial effects on clinically relevant bacteria including MRSA. While the B3 glass
alone was sufficient to produce antibacterial effects on select bacteria, adding dopants enhanced the broad-spectrum antibacterial properties: Live-Dead staining fluorescence microscopy suggests cell membrane integrity is disrupted in gram positive
bacteria exposed to the glass compounds, but not gram negative bacteria, indicating
multiple mechanisms of action for each glass formulation.
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1. Introduction
Hospital-acquired infection, also known as nosocomial infection, is a major health care
problem that results in longer hospital stays, an increase in the cost of healthcare, and
health risks in patients. Common sites for nosocomial infections include medical implants [1] [2] wounds, the urinary tract and the respiratory tract [2].
The presence of infection is not only a problem at the site of the medical implant, but
in the surrounding structures and tissues. Chronic bone infections like osteomyelitis
can result from infection in surrounding soft tissue [3], adding more complications to
infections acquired after surgery or the implantation of a medical device. Because of
DOI: 10.4236/aim.2016.610076 September 6, 2016
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their biocompatibility, bioactive glasses show promise as materials that can be used for
medical implants and may reduce the risk of infection.
Bioactive glass can be defined as a glass-ceramic material that is both biocompatible
and surface reactive. This class of biomaterials was originally developed to address the
problem of rejection associated with metal or plastic surgical implants [4]. In addition,
bioactive glasses have been developed for bone and tissue repair, dental and maxillofacial repair [5], and soft tissue repair [1] and have also been used as drug delivery vehicles for bone disease and infection [3] [6] [7].
Recently, bioactive glass research has undergone rapid growth, with the number of
papers published in the field doubling between the years 2000 and 2011 [8]. The use of
borate-based bioactive glasses as an alternative to silicate-based bioactive glasses has
also been an emerging trend in the field of biomaterials. Since borate bioactive glasses
do not yet have the well-established history of silicate bioactive glasses, there is still little known about their benefits and mechanisms in biological applications [7].
One benefit of borate bioactive glasses is that their reaction rate can easily be altered
by the boron content of the glass [3]. Easily changing the reaction rate of the glass is
beneficial, as this allows for the surface-reactivity of the glass to be tailored to its specific use on a case-by-case basis. In addition, borate glasses have been shown to have
added biological effects. For instance, borate-based bioactive glasses have been shown
to promote cell proliferation, cell differentiation [8], and promote wound healing [9].
Borate alone has also been shown to have antimicrobial properties, and has actually
been used as an ancient remedy to soothe skin infections and wounds [10]. While the
antimicrobial capabilities of borate-based biomaterials are not well documented, borate
chemistry in solution has been studied, and potential mechanisms include energy depletion by binding NAD and NADH [11] [12], and initiating DNA damage by binding to
ribose groups [11]-[13].
Glass 13-93B3 (B3), a novel bioactive borate glass, is currently undergoing clinical
trials for its wound healing abilities [9]. While little is known about the exact mechanism by which the glass stimulates wound healing, this property of B3 makes it a promising borate-based bioactive glass to be used in clinical applications. The addition of
metal ions to B3 enhances wound healing, angiogenesis and nerve cell growth.
In addition to modifying their reactive properties, modifying bioactive glasses with
metal ions can also make the glasses antimicrobial. Silver has long been known to have
antimicrobial properties, and has been incorporated into various materials to inhibit
bacterial growth. Silver ions are typically incorporated into the bioactive glass as silver
oxide (Ag2O) which leaches out of the glass to inhibit microbial growth. Because bioactive glass is porous [13] and can have its reaction rate adjusted by changes to its composition [4], incorporation of silver ions into a bioactive glass allows for a slow, controlled delivery of the ions over an extended period of time..
Bellantone and colleagues showed that a silver oxide-doped silicate glass showed
bactericidal activity against Staphylococcus aureus, Escherichia coli, and Pseudomonas

aeruginosa over a 20 hour incubation period. Their study also showed that levels of free
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silver in solution decreased over time, meaning that the bacteria were taking up the silver ions before dying [14]. These findings suggest that the silver ions have bactericidal
effects by interacting with intracellular components of the bacteria, rather than interaction with the cell wall or outer membranes of the cells. In addition, it was noted that
reactivity of bioactive glasses in water results in a slight increase in pH yet the increase
in pH alone is not sufficient to kill the bacteria in solution [14].
Other studies have also shown antimicrobial activity of silver-doped bioactive glasses
against various bacteria. Overall, the presence of silver ions in bioactive glass has bactericidal properties against E. coli [14]-[17], Bacillus anthracis [15], Pseudomonas pyo-

cyanea [15], P. aeruginosa [13] [16], Candida albicans [16], Salmonella sp. [15], Streptococcus sp. [15], and S. aureus [13] [16] [18]. Silver ions in solution have also shown
antimicrobial efficacy against P. aeruginosa, S. aureus, and C. albicans when in combination with natural products [19]. Additionally, silver nanoparticles have been incorporated into polymers and have also shown antimicrobial effects [17] [20] [21]. These
previous studies show that silver is a reliable antimicrobial component of silicate based
bioactive glasses, and is likely to have bactericidal capabilities if integrated into a novel
bioactive glass such as B3.
Since silver-doped silicate bioactive glasses are well-studied, there are various proposed mechanisms for how silver inhibits bacterial growth and gives bioactive glass
bactericidal capabilities. Such proposed mechanisms include complexing with thiol [1],
sulfydryl, amino, or hydroxyl functional groups [13], competing with copper ions as a
cofactor in transport or enzymatic reactions [13], general toxicity [13] [22], disruption
of aliphatic carbon-hydrogen bonds by insertion of carbenes [23], DNA damage by
arene-purine hydrophobic interactions [23], direct binding to DNA [1], increased permeability and disruption of cell membranes [1], and inhibition of respiratory [1] or
signaling [21] enzymes.
While the addition of silver is a historically reliable means of introducing bactericidal
capabilities to silicate based bioactive glass, the use of other ions is gaining popularity
[24]. Valappil and colleagues showed a decrease in P. aeruginosa viability after exposure to a gallium-doped bioactive glass, as well as a reduction of biofilm growth [25]
[26]. Doping bioactive glass with other ions, such as yttrium, selenium, and iodine also
show potential for antimicrobial activity [21] [24]. Gallium doped sol-gel phosphatebased glasses have also shown promising antimicrobial activity against S. aureus and

Streptococcus mutans [27] and phosphate based glasses doped with both silver and gallium have been shown to be effective against P. aeruginosa biofilm formation [25].
Further studies have revealed that antimicrobial effects of gallium are likely intracellular and involve disruption of bacterial iron uptake [27] [28].
From these findings, it is clear that the presence of borate as well as various ions, including gallium and iodine, may enhance the bactericidal activity of borate bioactive
glasses. The broad-spectrum antimicrobial activity of the borate bioactive glass, B3,
doped with silver, gallium, and iodine as well as B3 alone was tested against a variety of
clinically relevant pathogens. In addition, the mechanism of action by which the bioac778
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tive glasses worked against both gram-negative and gram-positive bacteria was further
studied by Live-Dead fluorescence microscopy.

2. Methods
Bacterial Strains
All bacterial strains used in the following experiments are described in Table 1.
Glass Composition
Bioactive glasses were prepared in the Missouri S & T Department of Materials
Science and ground to a particle size of less than 45 micrometers. The composition of
each glass used is given in Table 2.
Well Diffusion Assay
100 ul of overnight broth culture grown in Trypticase Soy Broth (TSB) (Difco Labs,
Detroit, MI) was plated in triplicate on Trypicase Soy Agar (TSA) (Difco Labs, Detroit,
Table 1. Bacterial isolates used in experiments.
Organism

Clinical Relevance

Source*

Enterobacter cloacae

Abdominal infections, abscesses, urinary tract infections

Difco (23355)

Escherichia coli

Enteric disease, urinary tract infections

ATCC (25922)

Klebsiella
pneumoniae

Urinary tract infections, pneumonia

Difco (13883)

Moraxella catarrhalis

Respiratory tract infections, meningitis

Carolina (154928)

Proteus mirabilis

Urinary tract infections

Carolina (155239)

Proteus vulgaris

Wound infections, urinary tract infections

Carolina (155240)

Pseudomonas
aeruginosa

Wound infections, burn infections,
pneumonia, urinary tract infections

Difco (27853)

Serratia marcescens

Respiratory tract infections,
urinary tract infections, conjunctivitis

Difco (8100)

Shigella flexneri

Enteric disease, abdominal infections

ATCC (12022)

Shigella sonnei

Enteric disease, abdominal infections

ATCC (25931)

Vibrio natriegens

Vibrio species, simulant for Vibrio cholera

ATCC 14048

Enterococcus faecalis

Urinary tract infections, subacute endocarditis

Carolina (155600)

Staphyloccus aureus
(MRSA)

Skin infections, wound infections, abscesses,
surgical infections, osteomyelitis, enteric disease

ATCC (BAA-44)

Staphylococcus
epidermidis

Chronic skin infections, bacterial endocarditis
from ventriculo-atrio shunts/implants

Difco (12228)

Staphylococcus
epidermidis

Biofilm forming clinical isolate from medical implant

ATCC (35984)

Gram-negative
organisms

Gram-positive
organisms

*ATCC (American Type Culture Collection) (ATCC number); Carolina (Carolina Biological Supply) (Carolina Biological Supply item number); Difco (Difco Bactrol Disks, Difco Laboratories) (ATCC number).
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Table 2. Compositions of bioactive glasses used.
Percent Weight
Component

B3

B3-Ag

B3-Ga

B3-I

B2O3

53%

52%

52%

53%

CaO

20%

20%

20%

20%

K2O

12%

12%

12%

10%

Na2O

6%

6%

6%

6%

MgO

5%

5%

5%

5%

P2O5

4%

4%

4%

4%

Ag2O

-

1%

-

-

Ga2O3

-

-

1%

-

I

-

-

-

2%

Compositions of bioactive glasses used.

MI) plates to make wells in each plate, a sterile, plastic tube was dipped into 70% ethanol for 10 seconds, allowed to air dry, and then plunged into the TSA plate and removed. The plug of TSA was then discarded. To the well, 20 µl of molten agar was
added and allowed to cool to seal the bottom of each well.
Glass suspensions were prepared by suspending 100 mg of glass powder in 500 mL
sterile saline solution. 50 µl of glass solution (10 mg glass) was added to each well. The
plates were incubated at 37˚C for 24 hours. After incubation, the distance between the
edge of the well to the beginning of bacterial growth on the plate was measured to determine the zone of inhibition.
A 2-way ANOVA of the sensitivity data comparing the size of the zone of inhibition
of each glass formula to control for each bacterial species was performed to determine
differences in sensitivity of different bacteria to the four glass formulas.
Live-Dead Staining Assay
Samples were prepared in accordance with the Bio-Rad Live-Dead staining kit. 50ul
of glass solution (prepared as described above) was added to 1 ml of overnight broth
culture, and the mixture was centrifuged at 1100 rpm for 10 minutes. After removal of
the supernatant, the pellet was re-suspended in 500 ul of staining buffer (including
PropodiumIodided and Live-DyeTM) and incubated at 37˚C for 15 minutes. After incubation, a slide was prepared by spotting 5ul of the solution on a glass microscope slide
and covered with a glass coverslip. The slide was then viewed using the Olympus IX51
inverted microscope at 4000× using Fluorescein Isothiocyanate (FITC), Texas Red
(TxRed), and Differential Interference Contrast (DIC) filters. Channel images were
captured with a Hamamatsu digital camera, and the number of live cells was determined by counting the number of green cells, which were viewed through the FITC
channel. The number of dead cells was determined as the number of red cells, which
were viewed in the TxRed channel. The total number of cells was the sum of live and
dead cells for the given field, and percent viability was determined as the percentage of
780
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live cells over the total number of cells. Changes in viability compared to controls were
analyzed using a one-way ANOVA with α = 0.05.

3. Results
Based on the well diffusion assay, gram positive and gram negative bacteria showed
sensitivity to each glass, however, the glasses appeared to have a greater antimicrobial
effect on gram positive species. The borate in the B3 glass alone was sufficient to inhibit
growth for E. coli, Shigella sonnei, Vibrio natriegens, Staphylococcus epidermidis
12,228, Serratia marscesens, and methicillin resistant S. aureus (MRSA), as the zone of
inhibition was significantly greater than the B3 glass control composition (Figure 1).
Addition of ions to the B3 glass had varied effects on antimicrobial activity. Growth of

Moraxella catarrhalis was inhibited significantly only with the Iodine-containing glass
formulation (Figure 1). The addition of iodine to the B3 glass formulation improved or
maintained the antimicrobial properties of B3 against MRSA, S. marscesens, S. epider-

midis, and E. coli (Figure 1). However, Iodine addition decreased the antimicrobial
properties of B3 against V. natriegens and S. sonnei (Figure 1). The addition of silver to
B3 drastically improved antimicrobial activity against S. epidermidis 12,228 but was
actually the least effective glass formulation against MRSA.
Live-Dead staining fluorescence cicroscopy was used to further evaluate the potential
mechanism of action of each glass formulation against gram negative and gram positive
bacteria.

This method uses differential dyes in order to differentiate cells with intact

cell membranes (live) from cells with disrupted cell membranes (dead). LiveDye selectively binds intact membranes and fluoresces green under a FITC filter while PI intercalates intracellular DNA and is viewed as red through a TxRed filter. PI does not pass
through intact cell membranes to bind DNA, so it will only be visible if the cell membrane has been disrupted.

Figure 1. Sensitivity of bacteria to borate glasses. *= p ≤ 0.05; **= p ≤ 0.01; ***= p ≤ 0.001; ****= p ≤
0.0001.
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The viability of bacterial cells determined by Live-Dead staining appeared to decrease
markedly for MRSA and S. epidermidis 12,228, but did not decrease significantly for E.
coli with exposure to glass compositions. MRSA and S. epidermidis 12,228 treated with
B3-Ga and B3-I had significant decreases in viability compared to controls after
15-minute incubation (Figure 2 and Figure 3). After 24-hour incubation, MRSA viability
significantly decreased with contact with the B3, B3-Ag, and B3-I glasses, but interestingly, did not have a significant decrease in contact with the B3-Ga glass (Figure 2).
Likewise, the percent viability of S. epidermidis also decreased after 24 hour incubation with each glass, most significantly with B3-Ga and B3-I. However only contact
with B3, B3-Ag, and B3-Ga resulted in significant decreases in viability after a 15
minute incubation period (Figure 3).
Given that E. coli was most sensitive to B3 and B3-Ag in well-diffusion assays, only
these two glasses were used in Live-Dead staining microscopy assays. The viability of E.
coli based on the Live-Dead staining did not decrease significantly with any of these
glass formulations after either a 15 minute or 24 hour incubation period (Figure 4).

Figure 2. Live-dead staining of MRSA. *= p ≤ 0.05; **= p ≤ 0.01; ***= p ≤ 0.001; ****= p ≤ 0.0001.

Figure 3. Live-dead staining of S. epidermidis 12,228. *= p ≤ 0.05; **= p ≤ 0.01; ***= p ≤ 0.001; ****=
p ≤ 0.0001.
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Figure 4. Live-dead staining of E. coli. *= p ≤ 0.05; **= p ≤ 0.01; ***= p ≤ 0.001; ****= p ≤ 0.0001.

4. Discussions
One of the most serious nosocomial pathogens plaguing hospitals today is Methicillin-resistant Staphylococcus aureus (MRSA). MRSA infection has many risk factors, including recent surgery or hospital stay, the presence of a medical implant, such as a catheter and undergoing dialysis [2]. Recent surgery or the presence of a medical implant
can be said to be the most significant risk factors, as the presence of a surgical implant
decreases the minimum infectious dose of MRSA by 100,000 fold [3]. While there are
numerous risk factors for MRSA infection, otherwise healthy individuals with no risk
factors can also acquire MRSA infections, making MRSA not only a nosocomial pathogen, but also a community-associated pathogen [2].
Other nosocomial pathogens besides MRSA are also relevant when considering recent surgery or the presence of a medical implant as a risk factor. For instance, E. coli
and P. aeruginosa have been found at surgical implant sites and have been implicated in
infections after surgical procedures and urinary catheters [4]. The presence of biofilmforming bacteria poses an increased risk of infection at implant sites, as these bacteria
are usually more resistant to antibiotic treatment as well as host defenses [29] and gain
protection from surrounding bacteria within the biofilm at the infection site [1]. Other
risk factors that can predispose a patient to an implant-associated infection include old
age and pre-existing health conditions, such as diabetes mellitus, rheumatoid arthritis,
or HIV infection [30]. In addition to complications such as osteomyelitis, other factors
contribute significantly to the seriousness of nosocomial infections. For instance, one
study reported that MRSA infections were responsible for more deaths in the United
States than AIDS [31] making prevention of nosocomial infections, especially MRSA, a
critically important field of research.
Overall, the glass formulations tested in the present work appeared to have a broad
spectrum of antimicrobial activity, inhibiting growth of both gram negative and gram
positive organisms. Borate (B2O3) alone in the B3 formulation was sufficient to inhibit
growth of E. coli, S. sonnei, V. natriegens, S. epidermidis 12,228, S. marcescens, and
783
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MRSA, while the addition of other ions to the B3 glass had varied effects on antimicrobial activity and specific sensitivities of bacteria (Figure 1). This suggests borate
based bioactive glasses may have inherent antimicrobial activity, which could be considered an advantage to their use as an alternative to silicate based bioactive glasses.
However, the addition of ions to the B3 glass resulted in lack of significant difference in
growth inhibition compared to controls for S. sonnei, suggesting addition of these ions
provided a protective factor for reducing the effect of B3 glass against this species.
Conversely, the addition of ions showed increased antimicrobial activity of the B3 glass
for most of the other susceptible species (Figure 1). Addition of silver ions was especially effective in increasing antimicrobial activity of B3 against E. coli and S. epidermidis 12,228, while the addition of gallium ions reduced the antimicrobial activity against
E. coli (Figure 1). M. catarrhalis, however, was sensitive only to the B3 glass that contained iodine ions (Figure 1). This suggests that gallium and iodine are potential candidates for use in bioactive borate glasses in order to provide antimicrobial coverage to
pathogens that are not sensitive to silver.
MRSA was sensitive to all four glass formulations, but least sensitive to B3-Ag. Since
silver has long been used as an antimicrobial agent, the resistance mechanisms employed by MRSA to resist multiple antibiotic drugs may also allow the bacteria to partially resist the antimicrobial effects of B3-Ag glass (Figure 1).
Differences in sensitivity based on glass formulation suggest varied mechanisms of
action of each formulation and against different types of bacteria. To further evaluate
cell membrane disruption as a potential mechanism of action, Live-Dead Staining Fluorescence microscopy was used to determine changes in viability after 15 minute and
24 hour incubations with the different glass compositions. The Live-Dead staining allowed for discrimination between cells with intact cell membranes and cells with cell
membrane disruption that would lead to cell death. Viability determined by Live-Dead
staining was decreased for the gram positive bacteria, including MRSA (Figure 2) and
S. epidermidis 12,228 (Figure 3), after exposure to the glass formulations, but not for
the gram-negative bacteria, E. coli (Figure 4). This data suggests that while E. coli is
sensitive to most of the glass formulations as seen in the well-diffusion assay (Figure 1),
its growth is not inhibited by the glass disrupting the cell membrane. Further,
Live-Dead staining analysis of viability supported that the glass formulations exert antimicrobial activity on gram positive bacteria by a mechanism that disrupts cell membrane integrity. Differences in the effect of each glass formulation on viability depending on incubation time also reveals subtle differences in glass kinetics and duration of
action, allowing for a better understanding of how each glass formulation may behave
in vivo.
While each of the glass formulations were not effective against all of the bacteria
tested, the group of the bacteria found to be sensitive to the glass represent a sizeable
portion of clinically relevant pathogens capable of causing nosocomial infections. The
primary clinical application of these materials is as glass fibers for wound repair. The
use of glass ground to less than 45 micrometers was chosen to simulate the approximate
diameter of these fibers and mimic the behavior of the class when it contacts bodily
784
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fluids. Other potential uses of these borate-based glass formulations may be as coatings
for medical devices commonly associated with nosocomial infections in order to prevent infection by inhibition of bacterial growth. This can be accomplished by incorporating the 45 micrometer size particles into polymers and coatings to be applied to surfaces. The bioactive nature of these glass formulations also allows for their use as bone
grafts and tissue repair, allowing for a dual-purpose of the glass to both bind to and
react with bone while preventing or treating bone infections. The advantage of using
these antibacterial materials will be to minimize the occurrence of infections associated
with standard clinical procedures and reduce the need for antibiotics following procedures.
Further work to improve the efficacy of the glass formulations against clinically relevant bacteria, as well as fungi, and to more clearly elucidate the mechanism of action
for each formulation, is vital in guiding treatment decisions with clinical use of these
materials. Additionally, a B3 formulation including silver, gallium, and iodine in one
glass composition could be useful in making the materials have a wider spectrum of antimicrobial activity as well as potentially preventing future resistance to the glass formulations.
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